Company profile: Valbiotis
1.1 - Company Overview
Company description
- Provider of nutrition solutions to prevent cardiometabolic diseases and nutritional support for patients. Develops Valedia, in Phase II clinical trials for type 2 diabetes. Portfolio includes patented plant extract blends: TOTUM•63 for glycemic control, Lipidrive (TOTUM•070) for LDL reduction, TOTUM•854 for blood pressure, and TOTUM•448 for metabolic liver disease.
Products and services
- Lipidrive (TOTUM•070): A clinically-proven combination of plant extracts fabricated to reduce LDL cholesterol levels in individuals with mild to moderate hypercholesterolemia
- TOTUM•63: A multi-target blend of plant extracts engineered to lower fasting blood glucose and HbA1c in type 2 diabetes by modulating multiple pathophysiological mechanisms
- TOTUM•854: A patented combination of plant extracts developed to reduce blood pressure in mild-to-moderate elevation, directly addressing a key cardiovascular disease risk factor
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Valbiotis
Glanbia
HQ: Ireland
Website
- Description: Provider of global nutrition and performance nutrition products and ingredients, operating Flavor Producers to supply natural and organic flavors and extracts to food and beverage industries. Offers performance nutrition brands for physical and lifestyle needs, insights on yoghurt trends, and partners with Spartan via Optimum Nutrition to promote fitness and nutrition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Glanbia company profile →
BellRing Brands
HQ: United States
Website
- Description: Provider of protein shakes, bars, and powders; a spin-off of Post's active nutrition unit.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BellRing Brands company profile →
Ceres Pharma
HQ: Belgium
Website
- Description: Provider of pharmaceuticals, medical devices, cosmetics, and high-quality dietary supplements based on recent nutritherapy and phytotherapy findings. Develops, manufactures, and distributes prescription contraceptives (pills, IUDs, vaginal ring, emergency), vitamins and minerals (Innopharm in Hungary), traditional herbal products (Calmotusin in Romania), antibiotics, menopause treatments, and urology treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ceres Pharma company profile →
Youtheory
HQ: United States
Website
- Description: Provider of collagen and turmeric supplements as one of the largest U.S. manufacturers, offering collagen powders and capsules for hair, skin, nails and joint health; ashwagandha in capsules and gummies for stress support; spore probiotics in gummies and powders for digestive health; Lion's Mane + with Cognizin citicoline for cognitive support; Heart Capsule; and Ocean-Friendly Omega algae-based omega-3 for heart, brain and eye health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Youtheory company profile →
IxX Pharma
HQ: Belgium
Website
- Description: Provider of healthcare and nutritional supplements, manufacturing vitamin and mineral capsules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IxX Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Valbiotis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Valbiotis
2.2 - Growth funds investing in similar companies to Valbiotis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Valbiotis
4.2 - Public trading comparable groups for Valbiotis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →